SCHEMBL194404

SCHEMBL194404

O[C](O)COc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.65
KCNA3 P22001 1/20 0.55
ALDH1A1 P00352 1/20 0.54
RECQL P46063 1/20 0.54
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
MAOB P27338 3/20 0.50
AOC2 O75106 2/20 0.50
MAOA P21397 2/20 0.50
AOC3 Q16853 2/20 0.50
ALPL P05186 1/20 0.50
ALPI P09923 1/20 0.50
ALPG P10696 1/20 0.50
DAO P14920 1/20 0.50
HPGD P15428 1/20 0.48
LMNA P02545 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2966505 0.80
SCHEMBL1318870 0.79 ALOX15 (1.00) ALOX15ALDH1A1KMT2AMEN1ALPL
SCHEMBL19305271 0.79 ALOX15 (0.60) ALOX15KCNA3ALDH1A1RECQLKMT2A
SCHEMBL3898377 0.79 ALOX15 (0.74) ALOX15ALDH1A1KMT2AMEN1ALPL
SCHEMBL8127 0.79 ALOX15 (1.00) ALOX15ALDH1A1KMT2AMEN1ALPL
SCHEMBL97376 0.79 ALOX15 (0.60) ALOX15KCNA3ALDH1A1RECQLKMT2A
SCHEMBL6672327 0.79 ALOX15 (0.60) ALOX15KCNA3ALDH1A1RECQLKMT2A
SCHEMBL8158707 0.79 ALOX15 (0.60) ALOX15KCNA3ALDH1A1RECQLKMT2A
SCHEMBL9602194 0.79 ALOX15 (0.60) ALOX15KCNA3ALDH1A1RECQLKMT2A
SCHEMBL5707676 0.79 ALOX15 (0.60) ALOX15KCNA3ALDH1A1RECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11209734-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-11209733-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-11204554-B2 Oxime ester photoinitiators BASF SE 2021-12-21 US disclosed
EP-3019473-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2020-02-19 EP disclosed
US-10488756-B2 Oxime ester photoinitiators BASF SE (DE) 2019-11-26 US disclosed
EP-3354641-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2019-07-17 EP disclosed
US-10234761-B2 Oxime ester photoinitiators BASF SE (DE) 2019-03-19 US disclosed
EP-2847167-B9 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2019-02-20 EP disclosed
EP-3354641-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-08-01 EP disclosed
EP-2847167-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-07-18 EP disclosed
US-20040170924-A1 Oxime ester photoiniators having a combined structure CIBA CORPORATION 2004-09-02 US disclosed
WO-2004050653-A2 OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-06-17 WO disclosed
EP-1410109-A1 PHOTOSENSITIVE RESIN COMPOSITION Ciba SC Holding AG (CH) 2004-04-21 EP disclosed
EP-1395615-A1 OXIME ESTER PHOTOINITIATORS HAVING A COMBINED STRUCTURE Ciba SC Holding AG (CH) 2004-03-10 EP disclosed
US-6596445-B1 Initiators for photopolymerization of radically polymerizable compounds CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-22 US disclosed
WO-2003010602-A1 PHOTOSENSITIVE RESIN COMPOSITION CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-02-06 WO disclosed
WO-2002100903-A1 OXIME ESTER PHOTOINITIATORS HAVING A COMBINED STRUCTURE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-12-19 WO disclosed
US-20020020832-A1 Photosensitive resin composition CIBA SPECIALTY CHEMICALS CORP. 2002-02-21 US disclosed
US-20010012596-A1 For resist applications; thermostability, storage stability CIBA SPECIALTY CHEMICALS CORP. 2001-08-09 US disclosed
US-5663212-A Light-sensitive resin composition FUJI PHOTO FILM CO., LTD. (JP) 1997-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11209734-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 ALOX15 31/4885KCNA3 868/4885ALDH1A1 823/4885
US-10488756-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 ALOX15 31/4885KCNA3 868/4885ALDH1A1 823/4885
US-11204554-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 ALOX15 35/4885KCNA3 876/4885ALDH1A1 779/4885
US-10234761-B2 Oxime ester photoinitiators C9, C5, CBR3 ALOX15 242/4885KCNA3 685/4885ALDH1A1 2225/4885
US-11209733-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 ALOX15 31/4885KCNA3 868/4885ALDH1A1 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.